Derek Crowther

Professor Derek Crowther FRCP, FRCR (born 1937) is a British oncologist, and Professor Emeritus, School of Medical Sciences, University of Manchester.[1]


Professor

Derek Crowther

FRCP, FRCR
NationalityUnited Kingdom
Alma materSt Bartholomew's Hospital

Crowther was educated at University of Cambridge and studied medicine at St Bartholomew's Hospital, graduating in 1963.[2][3]

In 1973, he became the first Professor of Medical Oncology at the Christie Cancer Centre, University of Manchester. He was the second professor of medical oncology in the UK (the first being Gordon Hamilton Fairley).[4] He retired in 1997.[3]

He served as chair of the Leukemia Research Fund Clinical Trials Advisory Panel, and president of the Association of Cancer Physicians.[2][3]

He is a foundation scholar at Clare College, Cambridge.[3]

He was a member of the United Kingdom government's Gene Therapy Advisory Committee, which first convened in November 1993.[5] In June 2015 he came to public attention, when one of his patients, who had been given six months to live, 40 years earlier, was eighty years old.[6]

References
  1. Bronchud, Miguel H. (3 December 2003). Principles of Molecular Oncology. Springer Science & Business Media. ISBN 978-1-59259-664-5.
  2. "Derek Crowther, b 1937. - Manchester Medical Collection: Biographical Files A-G - Archives Hub". archiveshub.jisc.ac.uk. Retrieved 9 September 2022.
  3. Daphne Christie; Tilli Tansey, eds. (2003). Leukaemia. Wellcome Witnesses to Contemporary Medicine. History of Modern Biomedicine Research Group. ISBN 978-0-85484-087-8. OL 21078818M. Wikidata Q29581665.
  4. Monfardini, Silvio; Balducci, Lodovico (10 December 2021). "The History of Medical Oncology in Europe, 1955–1985". ascopost.com. Retrieved 9 September 2022.
  5. "Gene Therapy". Parliamentary Debates (Hansard). 2 December 1993. Retrieved 17 June 2017.
  6. "Patient given just six months to live but still alive 40 years later". Retrieved 17 June 2017.


This article is issued from Wikipedia. The text is licensed under Creative Commons - Attribution - Sharealike. Additional terms may apply for the media files.